HAP Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

HAP Trading’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-54,014	Closed	-$200K	–	2989
2021 Q3	$241K	Buy	+54,014	New	+$260K	0.01%	960
2019 Q4	–	Sell	-360,468	Closed	-$2.62M	–	1554
2019 Q3	$1.42M	Buy	360,468 +109,274	+44%	+$884K	0.12%	153
2019 Q2	$3.73M	Buy	251,194 +234,693	+1,422%	+$4.24M	0.29%	74
2019 Q1	$410K	Buy	16,501 +1,076	+7%	+$27K	0.04%	320
2018 Q4	$277K	Sell	15,425 -119	-0.8%	-$2.43K	0.02%	488
2018 Q3	$457K	Buy	+15,544	New	+$602K	0.03%	309
2016 Q2	–	Sell	-93,408	Closed	-$1.79M	–	1083
2016 Q1	$1.79M	Buy	+93,408	New	+$1.98M	0.13%	136

Other funds holding CLVS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Macquarie Group

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return